Date | Time | Source | Announcement |
---|---|---|---|
04 Oct 2018 | 02:58 PM | Result of EGM and Change of Name | |
27 Sep 2018 | 07:00 AM | IB announce agreement to develop a diagnostic tool | |
18 Sep 2018 | 07:00 AM | Proposed name change and notice of EGM | |
11 Sep 2018 | 09:00 AM | Director/PDMR Shareholding | |
11 Sep 2018 | 07:00 AM | Director/PDMR Shareholding | |
10 Sep 2018 | 07:00 AM | Half-year Report | |
06 Aug 2018 | 02:51 PM | Holding(s) in Company | |
06 Aug 2018 | 10:16 AM | Holding(s) in Company | |
06 Aug 2018 | 07:00 AM | Appointment of CEO to the Operating Subsidiaries | |
01 Aug 2018 | 04:28 PM | Publication of a Prospectus |
IQ-AI Ltd operates as an investment company. The principal activity of the group is the provision of convenient, cost-effective, and clinical treatments to patients in the field of medical imaging diagnostics, based on proven technologies. Its geographical segment includes Jersey and the United States of America and reportable segments are holding company expenses and medical software. The company derives a majority of revenue from the United States of America. It also supplies medical technology solutions and has a strong neuroimaging product portfolio.
IQ-AI share price listed in London at 87p in 1996.